Found: 15
Select item for more details and to access through your institution.
Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.
- Published in:
- Allergy & Asthma Proceedings, 2012, v. 33, n. 3, p. 265, doi. 10.2500/aap.2012.33.3570
- By:
- Publication type:
- Article
Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis?
- Published in:
- Allergy & Asthma Proceedings, 2009, v. 30, n. 2, p. 212, doi. 10.2500/aap.2009.30.3220
- By:
- Publication type:
- Article
A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.
- Published in:
- Allergy & Asthma Proceedings, 2008, v. 29, n. 6, p. 644, doi. 10.2500/aap.2008.29.3176
- By:
- Publication type:
- Article
Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.
- Published in:
- Allergy & Asthma Proceedings, 2007, v. 28, n. 4, p. 427, doi. 10.2500/aap.2007.28.3014
- By:
- Publication type:
- Article
Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prolonged Effectiveness of Bepotastine Besilate Ophthalmic Solution for the Treatment of Ocular Symptoms of Allergic Conjunctivitis.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2011, v. 27, n. 4, p. 385, doi. 10.1089/jop.2011.0005
- By:
- Publication type:
- Article
Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube<sup>®</sup>: a randomized clinical trial.
- Published in:
- Journal of Asthma & Allergy, 2019, v. 12, p. 71, doi. 10.2147/JAA.S150251
- By:
- Publication type:
- Article
Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis.
- Published in:
- Journal of Asthma & Allergy, 2018, v. 11, p. 29, doi. 10.2147/JAA.S160687
- By:
- Publication type:
- Article
Technical and clinical validation of an environmental exposure unit for ragweed.
- Published in:
- Journal of Asthma & Allergy, 2016, v. 9, p. 215, doi. 10.2147/JAA.S123547
- By:
- Publication type:
- Article
Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial.
- Published in:
- Ophthalmology & Therapy, 2022, v. 11, n. 4, p. 1449, doi. 10.1007/s40123-022-00520-z
- By:
- Publication type:
- Article
Theraphies offer relief to many patients.
- Published in:
- Optometry Times, 2012, v. 4, n. 2, p. 15
- By:
- Publication type:
- Article
Choosing the right eye drop.
- Published in:
- Optometry Times, 2011, v. 3, n. 2, p. 30
- By:
- Publication type:
- Article
Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects.
- Published in:
- Clinical Ophthalmology, 2019, v. 13, p. 403, doi. 10.2147/OPTH.S186092
- By:
- Publication type:
- Article
Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model.
- Published in:
- Clinical Ophthalmology, 2018, v. 12, p. 2617, doi. 10.2147/OPTH.S185835
- By:
- Publication type:
- Article
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%.
- Published in:
- Clinical Ophthalmology, 2014, v. 8, p. 1495, doi. 10.2147/OPTH.S66637
- By:
- Publication type:
- Article